[Uro-oncological research from the laboratory and clinical practice].
This report presents current work and results of projects in the uro-oncological field from the Cantonal Hospital of St. Gallen. The first part deals with dendritic cell-based immunotherapy of hormone refractory prostate cancer. In the second part, some recent results of clinical and laboratory work for non-muscle invasive bladder cancer are highlighted.
Engeler
D
D
Klinik für Urologie, Kantonsspital, Rorschacher Strasse 95, CH-9007, St. Gallen, Switzerland. daniel.engeler@kssg.ch
Ludewig
B
B
Schmid
H-P
HP
D035843:Biomedical Research / Q000379:methods*; D003713:Dendritic Cells / Q000637:transplantation*; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000379:methods*; D011471:Prostatic Neoplasms / Q000601:surgery*; D013557:Switzerland; D001749:Urinary Bladder Neoplasms / Q000628:therapy*; D014572:Urology / Q000379:methods*